Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04090866 · ClinicalTrials.gov registry record
Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study
A clinical trial, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- 2
- Enrollment target
NCT04090866: Clinical Trial study, sponsored by University of Wisconsin, Madison.
NCT04090866 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04090866 was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Pulmonary arterial hypertension(PAH) is associated with the development of right heart failure. In the setting of heart failure, the heart shifts to increasing dependence on glucose metabolism. In this study, the investigators will perform cardiac positron emission tomography/magnetic resonance imaging (PET/MRI) scans to measure glucose metabolism in the heart before and after initiation of pulmonary vasodilator therapy for pulmonary arterial hypertension.
Primary Outcome
Substrate flexibility is defined as the change in myocardial to blood pool glucose uptake rate from rest to exercise.
Interventions
- OTHER PET/MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-11-14 |
| Est. Completion | 2020-07-21 |
Why NCT04090866 stopped before completion
NCT04090866 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which PET/MRI is the first listed.
NCT04090866 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04090866 about?
NCT04090866 is a clinical study titled "Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study". Pulmonary arterial hypertension(PAH) is associated with the development of right heart failure. In the setting of heart failure, the heart shifts to increasing dependence on glucose metabolism. In this study, the investigators will perform cardiac positron emission tomography/magnetic resonance imag...
What is the current status of trial NCT04090866?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2019-11-14. Estimated completion is 2020-07-21.
What interventions are being tested in trial NCT04090866?
The interventions under investigation include: PET/MRI (OTHER).
Who is sponsoring clinical trial NCT04090866?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI